Falso, Silvia
 Distribuzione geografica
Continente #
EU - Europa 88
NA - Nord America 62
AS - Asia 57
SA - Sud America 22
OC - Oceania 3
AF - Africa 2
Totale 234
Nazione #
US - Stati Uniti d'America 59
CN - Cina 25
BR - Brasile 21
IT - Italia 20
SG - Singapore 19
FR - Francia 15
DE - Germania 13
SE - Svezia 9
FI - Finlandia 8
KR - Corea 6
GB - Regno Unito 5
ID - Indonesia 3
RU - Federazione Russa 3
AT - Austria 2
CA - Canada 2
CI - Costa d'Avorio 2
CZ - Repubblica Ceca 2
IE - Irlanda 2
LT - Lituania 2
NZ - Nuova Zelanda 2
PL - Polonia 2
PS - Palestinian Territory 2
AU - Australia 1
BE - Belgio 1
BG - Bulgaria 1
CO - Colombia 1
GR - Grecia 1
IN - India 1
LV - Lettonia 1
MX - Messico 1
NL - Olanda 1
UZ - Uzbekistan 1
Totale 234
Città #
Chandler 16
Singapore 12
Hefei 6
Helsinki 6
Seoul 6
North Bergen 5
Lauterbourg 4
Milan 4
New York 4
Ashburn 3
Düsseldorf 3
Falkenstein 3
Frankfurt am Main 3
Jakarta 3
Moscow 3
Rome 3
Seattle 3
Abidjan 2
Amsterdam 2
Bremen 2
Campinas 2
Dublin 2
Hamilton 2
Los Angeles 2
Naples 2
Portsmouth 2
Shenzhen 2
São Paulo 2
Toronto 2
Tubas 2
Turku 2
Xi'an 2
Abaetetuba 1
Araraquara 1
Athens 1
Beijing 1
Belo Horizonte 1
Bexley 1
Boston 1
Brno 1
Caxias do Sul 1
Chicago 1
Cleveland 1
Denver 1
Diamantino 1
Florence 1
Guarulhos 1
Hyderabad 1
Itajubá 1
Jucás 1
London 1
Marlborough 1
Marseille 1
Mexico City 1
Miracema do Tocantins 1
Nuremberg 1
Paracatu 1
Pescara 1
Prague 1
Princeton 1
Queens 1
Recife 1
Remígio 1
Riga 1
Roubaix 1
San Francisco 1
Santa Bárbara 1
Sertãozinho 1
Sofia 1
São José 1
Tashkent 1
Timbé do Sul 1
Videira 1
Warsaw 1
Washington 1
Wroclaw 1
Totale 161
Nome #
New onset of Susac syndrome after mRNA COVID-19 vaccine: a case report 62
Safety and tolerability of SARS-Cov-2 vaccination in patients with myasthenia gravis: A multicenter experience 52
New onset of Susac syndrome after mRNA COVID-19 vaccine: a case report 32
Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study 23
Comparison of Fixed and Live Cell-Based Assay for the Detection of AChR and MuSK Antibodies in Myasthenia Gravis 23
Cancer Frequency in MuSK Myasthenia Gravis and Histological Evidence of Paraneoplastic Etiology 18
Concordance between radioimmunoassay and fixed cell-based assay in subjects without myasthenia gravis: optimizing the diagnostic approach 15
Thymoma resection and myasthenia gravis: what is the neurological outcome in patients older than 65 years? 12
Complement inhibitor therapy in thymoma-associated myasthenia gravis: a real-world experience 10
Totale 247
Categoria #
all - tutte 1.392
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.392


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224 0 0 0 0 0 0 0 0 0 0 1 3
2022/202347 4 5 1 7 4 8 3 5 1 1 6 2
2023/202426 1 2 5 0 0 4 3 2 1 1 2 5
2024/2025170 2 3 5 5 8 4 25 4 27 27 55 5
Totale 247